Abstract
摘要
相似文献
1
Immunorestoration.
Symp Fundam Cancer Res. 1986;38:269-74.
2
Editorial: Thymic cells and humoral factors as therapeutic agents.
Pediatrics. 1976 May;57(5):643-6.
3
Present and future status of thymus transplantation.
Ann Clin Res. 1981;13(4-5):350-7.
4
[Primary immunologic deficiency syndromes in man].[人类原发性免疫缺陷综合征]
Arkh Patol. 1977;39(6):3-13.
5
Cellular engineering.细胞工程
Clin Bull. 1977;7(1):33-9.
6
Immunotherapy in two foals with combined immunodeficiency, resulting in graft versus host reaction.对两匹患有联合免疫缺陷的马驹进行免疫治疗，导致移植物抗宿主反应。
J Am Vet Med Assoc. 1977 Jan 15;170(2):167-75.
7
Bone marrow transplantation: cellular engineering to correct primary immunodeficiency, aregenerative anemia and pancytopenia.骨髓移植：用于纠正原发性免疫缺陷、再生障碍性贫血和全血细胞减少症的细胞工程。
Birth Defects Orig Artic Ser. 1975;11(1):377-9.
8
9
[Present status of treatment of immunodeficiency with special reference to cellular immunologic deficiency].免疫缺陷治疗的现状，特别提及细胞免疫缺陷
Nihon Rinsho. 1973 Dec;31(12):3441-7.
10
Bone marrow transplantation in immunosuppressed or congenitally immune deficient patients.
Transplant Proc. 1973 Sep;5(3):1291-8.
Zotero 插件